(Q44598125)

4 December 2017

title

Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants (English)

1 reference

4 December 2017

0 references

1 reference

1

1 reference

4 December 2017

Richard D Findlay

2

1 reference

4 December 2017

Manuel Durand

series ordinal

3

1 reference

4 December 2017

publication date

1 October 2003

1 reference

4 December 2017

published in

Early Human Development

1 reference

4 December 2017

volume

74

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

37-45

1 reference

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

The new BPD: an arrest of lung development

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Lung development and function in preterm infants in the surfactant treatment era.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Pituitary-Adrenal Suppression and Recovery in Preterm Very Low Birth Weight Infants after Dexamethasone Treatment for Bronchopulmonary Dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Timing of peak serum cortisol values in preterm infants in low-dose and the standard ACTH tests

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Early postnatal dexamethasone treatment and increased incidence of cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Early postnatal dexamethasone therapy for the prevention of chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2803%2900082-3

7 January 2021

10.1016/S0378-3782(03)00082-3

Identifiers

DOI

1 reference

4 December 2017

1 reference